• Medicine
  • 17 de junho
  • FDA to approve GSK & Spero Therapeutics' Tebipenem HBr
    2
  • 18 de junho
  • FDA to approve Merck's Welireg + Keytruda or Keytruda Qlex
    2
  • 28 de junho
  • FDA to approve Arcutis' Zoryve cream
    2
  • 29 de junho
  • FDA to approve Ionis' Olezarsen
    2
  • FDA to approve Viridian Therapeutics' Veligrotug
    2
  • 30 de dezembro
  • CDC to issue Level 4 warning by December 31
    2
  • FDA approves Retatrutide this year?
    2
  • FDA to approve Daraxonrasib this year
    2